Pacific Biomarkers Inc
Trending Articles
Related Content
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Regulatory
New diagnostics speed drug development
Drug-induced organ toxicity accounts for 30% of all drugs that fail to reach the market, so early detection in clinical trials could potentially reduce tdrug development time by a number of years. Novel biomarkers for the assessment of drug-induced toxicity are in development for use in clinical trials with the goal of being accurate and powerful in vitro diagnostics (IVDs) that could replace or augment less sensitive existing tests.